• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人白细胞释放组胺的补体激活要求:纯化的C3ahu和C5ahu对组胺释放的影响。

Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.

作者信息

Hartman C T, Glovsky M M

出版信息

Int Arch Allergy Appl Immunol. 1981;66(3):274-81. doi: 10.1159/000232831.

DOI:10.1159/000232831
PMID:6170591
Abstract

The activation of human sera for histamine release by zymosan and anti-BSA-BSA complexes at equivalence was dose dependent and associated with a marked fall in CH50, C3 and C5 hemolytic activities. Heat-aggregated IgG, though able to fix greater than 90% of human CH50 activity and produce a lesser fall in C3 and C5 activities than zymosan and BSA-anti-BSA complexes, was unable to induce basophil histamine release. Chemically purified human C3a and C5a each caused histamine release from human basophils; C5a was more potent than C3a. In addition, neither zymosan nor BSA-anti-BSA complexes released histamine when incubated with homozygous C3-deficient serum. The addition of C3a and C5a at suboptimal concentrations produced an additive effect of histamine release.

摘要

酵母聚糖和等当量的抗牛血清白蛋白-牛血清白蛋白复合物激活人血清以释放组胺呈剂量依赖性,并伴有CH50、C3和C5溶血活性显著下降。热聚集的IgG虽然能够固定超过90%的人CH50活性,并且与酵母聚糖和牛血清白蛋白-抗牛血清白蛋白复合物相比,C3和C5活性下降较小,但不能诱导嗜碱性粒细胞组胺释放。化学纯化的人C3a和C5a均可引起人嗜碱性粒细胞组胺释放;C5a比C3a更有效。此外,酵母聚糖和牛血清白蛋白-抗牛血清白蛋白复合物与纯合C3缺陷血清孵育时均不释放组胺。以次优浓度添加C3a和C5a可产生组胺释放的相加效应。

相似文献

1
Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.人白细胞释放组胺的补体激活要求:纯化的C3ahu和C5ahu对组胺释放的影响。
Int Arch Allergy Appl Immunol. 1981;66(3):274-81. doi: 10.1159/000232831.
2
Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.过敏毒素诱导人白细胞释放组胺:C3a与白细胞结合及组胺释放的研究。
J Clin Invest. 1979 Sep;64(3):804-11. doi: 10.1172/JCI109527.
3
Human C5a des Arg increases vascular permeability.人C5a去精氨酸产物可增加血管通透性。
J Immunol. 1981 Dec;127(6):2376-80.
4
Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.补体肽C3a和C5a诱导人皮肤肥大细胞解离后介质释放。
J Invest Dermatol. 1994 May;102(5):803-6. doi: 10.1111/1523-1747.ep12378589.
5
Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.金黄色葡萄球菌蛋白A及用于癌症血清疗法的固定化蛋白A试剂产生人C3a、C4a和C5a过敏毒素。
J Immunol. 1984 Aug;133(2):1057-63.
6
Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.C3a和C5a过敏毒素对豚鼠离体血管的作用。
J Pharmacol Exp Ther. 1984 Sep;230(3):749-54.
7
Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.屋尘螨蛋白酶通过对C3和C5进行蛋白水解加工产生过敏毒素。
J Allergy Clin Immunol. 1997 Aug;100(2):253-60. doi: 10.1016/s0091-6749(97)70233-1.
8
Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).补体介导的免疫沉淀抑制和溶解作用产生不同浓度的补体过敏毒素(C4a、C3a、C5a)。
Clin Exp Immunol. 1986 May;64(2):407-14.
9
Cardiac anaphylaxis. Complement activation as an amplification system.心脏过敏反应。补体激活作为一种放大系统。
Circ Res. 1989 Sep;65(3):847-57. doi: 10.1161/01.res.65.3.847.
10
Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).组胺在补体肽C3a和C5a-去精氨酸(经典过敏毒素)致痉挛作用中的作用
Agents Actions. 1982 Apr;12(1-2):118-21. doi: 10.1007/BF01965121.

引用本文的文献

1
Allergic eye disease mechanisms.过敏性眼病机制。
Br J Ophthalmol. 1998 Oct;82(10):1203-14. doi: 10.1136/bjo.82.10.1203.
2
C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.C3a是人类嗜酸性粒细胞的趋化因子,而非中性粒细胞的趋化因子。I. C3a对中性粒细胞的刺激继发于嗜酸性粒细胞的激活。
J Exp Med. 1995 Jun 1;181(6):2119-27. doi: 10.1084/jem.181.6.2119.
3
Inflammatory mediators released by complement-derived peptides.补体衍生肽释放的炎症介质。
Agents Actions. 1983 Aug;13(5-6):405-14. doi: 10.1007/BF02176403.
4
Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.补体替代途径的B蛋白和H蛋白对免疫复合物及酵母聚糖介导的过敏毒素生成的调控
Immunology. 1984 Jan;51(1):123-31.
5
Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a).补体介导的免疫沉淀抑制和溶解作用产生不同浓度的补体过敏毒素(C4a、C3a、C5a)。
Clin Exp Immunol. 1986 May;64(2):407-14.
6
Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a.白细胞介素3和粒细胞/巨噬细胞集落刺激因子使人类嗜碱性粒细胞对低浓度的补体成分C3a产生反应。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6813-7. doi: 10.1073/pnas.87.17.6813.